ISIN: DE000A286LP0 Common Code: 227506199 German Securities Code (WKN): A286LP QIAGEN N.V. with corporate seat (statutaire zetel) in Venlo, The Netherlands (the "Issuer") GLOBAL BEARER BOND representing up to USD 500,000,000 (in words: five hundred...Qiagen N.V. • March 5th, 2021 • Biological products, (no disgnostic substances)
This global bearer bond (the "Global Bond") represents convertible bonds of the Issuer in the aggregate principal amount of up to USD 500,000,000, divided into Bonds in the principal amount of USD 200,000 each (the "Bonds"), and having the provisions specified, in the Terms and Conditions as annexed hereto. Definitive bonds representing the Bonds will not be issued. References in this Global Bond to the "Terms and Conditions" shall be to the Terms and Conditions as annexed hereto. Words and expressions defined or set out in the Terms and Conditions shall have the same meaning when used in this Global Bond.
ContractSubscription Agreement • March 5th, 2021 • Qiagen N.V. • Biological products, (no disgnostic substances)
EXECUTION VERSION Dated 10 December 2020 QIAGEN N.V.as Issuer andDEUTSCHE BANK AKTIENGESELLSCHAFTandGOLDMAN SACHS INTERNATIONALandMERRILL LYNCH INTERNATIONALas Joint Global Coordinators and Joint Bookrunners andBNP PARIBASandHSBC TRINKAUS & BURKHARDT AGandUNICREDIT BANK AGas Joint BookrunnersSUBSCRIPTION AGREEMENTrelating to theQIAGEN N.V.up to USD 500,000,000 Convertible Bonds due 2027ISIN DE000A286LP0convertible into ordinary registered shares of QIAGEN N.V. Linklaters Ref: L-305747 Linklaters LLP
